Catherine Guérin‐Charbonnel
- Molecular Biology top 5%
- Oncology top 5%
- Hematology top 1%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Wilfried GouraudL. CampionPascal JézéquelMario CamponeGabriel RicolleauStéphane MinvielleHervé Avet‐LoiseauPhilippe Moreau
- Topics
- Multiple Myeloma Research and Treatments (15 papers)Protein Degradation and Inhibitors (8 papers)Breast Cancer Treatment Studies (8 papers)
- Cited by
- HematologyCancer ResearchOncology
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Catherine Guérin‐Charbonnel
42 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 103
- Molecular Biology 1.7k
- Oncology 951
- Hematology 906
- Cancer Research 569
- Pulmonary and Respiratory Medicine 365
Countries citing papers authored by Catherine Guérin‐Charbonnel
This map shows the geographic impact of Catherine Guérin‐Charbonnel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Guérin‐Charbonnel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Guérin‐Charbonnel more than expected).
Fields of papers citing papers by Catherine Guérin‐Charbonnel
This network shows the impact of papers produced by Catherine Guérin‐Charbonnel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Guérin‐Charbonnel. The network helps show where Catherine Guérin‐Charbonnel may publish in the future.
Co-authorship network of co-authors of Catherine Guérin‐Charbonnel
This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Guérin‐Charbonnel. A scholar is included among the top collaborators of Catherine Guérin‐Charbonnel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Guérin‐Charbonnel. Catherine Guérin‐Charbonnel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 10 | |
| 7 | 9 | |
| 8 | 76 | |
| 9 | 30 | |
| 10 | 6 | |
| 11 | 13 | |
| 12 | 207 | |
| 13 | 34 | |
| 14 | 298 | |
| 15 | 24 | |
| 16 | 35 | |
| 17 | 269 | |
| 18 | 11 | |
| 19 | 34 | |
| 20 | 73 |
About Catherine Guérin‐Charbonnel
Catherine Guérin‐Charbonnel is a scholar working on Hematology, Cancer Research and Oncology, having authored 48 papers that have together received 2.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (15 papers), Protein Degradation and Inhibitors (8 papers) and Breast Cancer Treatment Studies (8 papers). The work is most often cited by research in Hematology (906 citations), Cancer Research (569 citations) and Oncology (951 citations). Catherine Guérin‐Charbonnel has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Wilfried Gouraud, L. Campion, Pascal Jézéquel, Mario Campone, Gabriel Ricolleau, Stéphane Minvielle, Hervé Avet‐Loiseau, Philippe Moreau, Michel Attal and Jean‐Luc Harousseau. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.